Page last updated: 2024-08-18

4-butyrolactone and Neuroleptic Malignant Syndrome

4-butyrolactone has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blayac, JP; Boulenger, JP; Capdevielle, D; Deddouche, C; Eiden, C; Peyrière, H1

Other Studies

1 other study(ies) available for 4-butyrolactone and Neuroleptic Malignant Syndrome

ArticleYear
Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Journal of addiction medicine, 2011, Volume: 5, Issue:4

    Topics: 4-Butyrolactone; Adult; Antipsychotic Agents; Clonazepam; Diagnosis, Differential; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Hallucinations; Humans; Infusions, Intravenous; Injections, Intramuscular; Loxapine; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Solvents; Substance Withdrawal Syndrome; Substance-Related Disorders

2011